Inherited variability of tumor necrosis factor production and susceptibility to infectious disease

Proceedings of the Association of American Physicians

Volumn 111, Issue 4, 1999, Pages 290-298

  Knight, J C ^a   Kwiatkowski, D ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cytokine; Genetics; Microsatellite; Polymorphism

Indexed keywords

TUMOR NECROSIS FACTOR;

CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA POLYMORPHISM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HOST RESISTANCE; HUMAN; PROMOTER REGION; REVIEW; TRANSCRIPTION REGULATION;

EID: 0032814655     PISSN: 1081650X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1381.1999.99237.x     Document Type: Review

References (50)

1. 1 Beutler B. & Cerami A. The biology of cachectin/TNF—a primary mediator of the host response. Ann. Rev. Immunol. 7: 625 656, 1989.
2. 2 Beutler B. Tumor Necrosis Factors. The Molecules and Their Emerging Role in Medicine. New York: Raven Press, 1992.
3. 3 Tracey K.J. & Cerami A. Tumor necrosis factor: A pleiotropic cytokine and therapeutic target. Annu. Rev. Med. 45: 491 503, 1994.
4. 4 Nedwin G.E., Naylor S.L., Sakaguchi A.Y., et al. Human lymphotoxin and tumour necrosis factor genes: Structure, homology and chromosomal location. Nucleic Acids Res. 13: 6361 6373, 1985.
5. 5 Spies T., Morton C.C., Nedospasov S.A., et al. Genes for the tumour necrosis factors alpha and beta are linked to the human major histocompatibility complex. Proc. Natl. Acad. Sci. U.S.A. 83: 8699 8702, 1986.
6. 6 Molvig J., Baek L., Christensen P., et al. Endotoxin‐stimulated human monocyte secretion of interleukin 1, tumour necrosis factor alpha, and prostaglandin E2 shows stable interindividual differences. Scand. J. Immunol. 27: 705 716, 1988.
7. 7 Westendorp R.G.J., Langermans J.M., Huizinga T.W.J., et al. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 349: 170 173, 1997.
8. 8 Jacob C.O., Fronek Z., Lewis G.D., et al. Heritable major histocompatibility complex class II‐associated differences in production of tumor necrosis factor alpha: Relevance to genetic predisposition to systemic lupus erythematosus. Proc. Natl. Acad. Sci. U.S.A. 87: 1233 1237, 1990.
9. 9 Bouma G., Crusius J.B.A., Pool M.O., et al. Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA‐DR alleles. Relevance for inflammatory bowel disease. Scand. J. Immunol. 43: 456 463, 1996.
10. 10 Turner D.M., Grant S.C.D., Lamb W.R., et al. A genetic marker of high TNF alpha production in heart transplant recipients. Transplantation 60: 1113 1117, 1995.
11. 11 Pociot F., Briant L., Jongeneel C.V., et al. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF alpha and TNF beta by human mononuclear cells: A possible link to insulin‐dependent diabetes mellitus. Eur. J. Immunol. 23: 224 231, 1993.
12. 12 Messer G., Spengler U., Jung M.C., et al. Polymorphic structure of the tumor necrosis factor (TNF) locus: An NcoI polymorphism in the first intron of the human TNF‐beta gene correlates with a variant amino acid at position 26 and a reduced level of TNF‐beta production. J. Exp. Med. 173: 209 219, 1991.
13. 13 Pociot F., D’alfonso S., Compasso S., et al. Functional analysis of a new polymorphism in the human TNF alpha gene promoter. Scand. J. Immunol. 42: 501 504, 1995.
14. 14 Sariban E., Imamura K., Luebbers R., Kufe D. Transcriptional and posttranscriptional regulation of tumour necrosis factor gene expression in human monocytes. J. Clin. Invest. 81: 1506 1510, 1988.
15. 15 Yao J., Mackman N., Edington T.S., Fan S.T. Lipopolysaccharide induction of the tumor necrosis factor‐alpha promoter in human monocytic cells. J. Biol. Chem. 272: 17795 17801, 1997.
16. 16 Wilson A.G., Symons J.A., McDowell T.L., et al. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc. Natl. Acad. Sci. U.S.A. 94: 3195 3199, 1997.
17. 17 Kroeger K.M., Carville K.S., Abraham L.J. The −308 tumor necrosis alpha promoter polymorphism effects transcription. Mol. Immunol. 34: 391 399, 1997.
18. 18 Brinkman B.M.N., Zuijdgeest D., Kaigzel E.L., et al. Relevance of the tumor necrosis factor alpha −308 promoter polymorphism in TNF alpha gene regulation. J. Inflamm. 46: 32 41, 1996.
19. 19 Stuber F., Udalova I.A., Book M., et al. −308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter. J. Inflamm. 46: 42 50, 1996.
20. 20 Fong C.W., Siddiqui A.H., Mark D.F. Identification and characterisation of a novel repressor site in the human tumour necrosis factor alpha gene. Nucleic Acids Res. 22: 1108 1114, 1994.
21. 21 Jepson A., Sisay‐Joof F., Banya W., et al. Genetic linkage of mild malaria to the major histocompatibility complex in Gambian children: Study of affected sibling pairs. Br. Med. J. 315: 96 97, 1997.
22. 22 Blackwell J.M., Black G.F., Peacock C.S., et al. Immunogenetics of leishmanial and mycobacterial infections: The Belem Family Study. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 352: 1331 1345, 1997.
23. 23 Levee G., Schurr E., Pandey J.P. Tumor necrosis factor‐alpha, interleukin‐1‐beta and immunoglobulin (GM and KM) polymorphisms in leprosy. Exp. Clin. Immunogenet. 14: 160 165, 1997.
24. 24 Risch N. & Merikangas K. The future of genetic studies of complex human diseases. Science 273: 1516 1517, 1996.
25. 25 Rudwaleit M., Tikly M., Khamashta M., et al. Interethnic differences in the association of tumor necrosis factor promoter polymorphisms with systemic lupus erythematosus. J. Rheumatol. 23: 1725 1728, 1996.
26. 26 Awdeh Z.L., Raum D., Yunis E.J., Apler C.A. Extended HLA/complement allele haplotypes: Evidence for T/t‐like complex in man. Proc. Natl. Acad. Sci. U.S.A. 80: 259 263, 1983.
27. 27 McGuire W., Hill A.V.S., Allsopp C.E.M., et al. Variation in the TNF‐alpha promoter region associated with susceptibility to cerebral malaria. Nature 371: 508 511, 1994.
28. 28 Conway D.J., Holland M.J., Bailey R.L., et al. Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF‐alpha) gene promoter and with elevated TNF‐alpha levels in tear fluid. Infect. Immun. 65: 1003 1006, 1997.
29. 29 DeVries R.R., Fat R.F., Nijenhuis L.E., VanHood J.J. HLA‐linked genetic control. of host response to mycobacterium leprae. Lancet ii: 1328 1330, 1976.
30. 30 Roy S., McGuire W., Mascie‐Taylor C.G.N., et al. Tumor necrosis factor polymorphism and susceptibility to lepromatous leprosy. J. Infect. Dis. 176: 530 532, 1997.
31. 31 Goldfeld A.E., Delgado J.C., Thim S., et al. Association of an HLA‐DQ allele with clinical tuberculosis. J.A.M.A. 279: 226 228, 1998.
32. 32 Cabrera M., Shaw M., Sharples C., et al. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J. Exp. Med. 182: 1259 1264, 1995.
33. 33 Nadel S., Newport M.J., Booy R., Levin M. Variation in the tumor necrosis factor‐alpha gene promoter region may be associated with death from meningococcal disease. J. Infect. Dis. 174: 878 880, 1996.
34. 34 Just J.J. Genetic predisposition to HIV‐1 and acquired immunodeficiency virus syndrome. Hum. Immunol. 44: 156 169, 1995.
35. 35 Matsuyama T., Kobayashi N., Yamamoto N. Cytokines and HIV infection: Is AIDS a tumor necrosis factor disease. A.I.D.S. 5: 1405 1417, 1991.
36. 36 Brinkman B.M.N., Keet I.P.M., Miedema F., et al. Polymorphisms within the human tumor necrosis factor‐alpha promoter region in human immunodeficiency virus type‐1 seropositive persons. J. Infect. Dis. 175: 188 190, 1997.
37. 37 Khoo S.H., Pepper L., Snowden N., et al. Tumour necrosis factor c2 microsatellite allele is associated with the rate of HIV disease progression. A.I.D.S. 11: 423 428, 1997.
38. 38 Choo S.Y., Spies T., Strominger J.L., Hansen J. Polymorphism in the tumor necrosis factor gene: Association with HLA B and DR haplotypes. Hum. Immunol. 23: 86, 1988.
39. 39 Ferencik S., Lindemann M., Horsthemke B., Grosse‐Wilde H. A new restriction fragment length polymorphism of the human TNF‐beta gene detected by AspHI digest. Eur. J. Immunol. 19: 425 430, 1992.
40. 40 Hamann A., Mantzoros C., Vidal‐Puig A., Flier J.S. Genetic variability in the TNF‐alpha promoter is not associated with type II diabetes mellitus (NIDDM). Biochem. Biophys. Res. Commun. 211: 833 839, 1995.
41. 41 Wilson A.G., DiGiovine F.S., Blakemore A.I.F., Duff G.W. Single base change in the human tumour necrosis factor alpha gene detectable by NcoI restriction of the PCR product. Hum. Mol. Genet. 1: 353, 1992.
42. 42 Zimmerman P., Hunter J., Bailey E., et al. Tumor necrosis factor alpha promoter mutation frequencies among four North American racial groups. Immunology 49 (4): S2, 1996.
43. 43 D’alfonso S. & Richiardi P.M. A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics 39: 150 154, 1994.
44. 44 Brinkman B.M.N., Kaijzel E.L., Huizinga T.W.J., et al. Detection of a novel C‐insertion polymorphism within the human tumor necrosis factor alpha gene. Hum. Genet. 96: 493 495, 1995.
45. 45 D’alfonso S.M.P. A new polymorphism in the TNFA gene [abstract]. Hum. Immunol. 47: 65, 1996.
46. 46 Wilson A.G., Vries D., Pociot F., et al. An allelic polymorphism within the human tumour factor alpha promoter region is strongly associated with HLA A1, B8 and DR3 alleles. J. Exp. Med. 177: 557 560, 1993.
47. 47 D’alfonso S., Colombo G., Bella S.D., et al. Association between polymorphisms in the TNF region and systemic lupus erythematosus in the Italian population. Tissue Antigens 47: 551 555, 1996.
48. 48 Brinkman B., Giphart M.J., Verhoef A., et al. Tumor necrosis factor alpha‐308 gene variants in relation to major histocompatability alleles and Felty’s syndrome. Hum. Immunol. 41: 259 266, 1994.
49. 49 Dawkins R.L., Leaver A., Cameron P.U., et al. Some disease‐associated ancestral haplotypes carry a polymorphism of TNF. Hum. Immunol. 26: 91 97, 1989.
50. 50 Udalova I.A., Nedospasov S.A., Webb G.C., et al. Highly informative typing of the human TNF locus using six adjacent polymorphic markers. Genomics 16: 180 186, 1993.